These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2860529)

  • 1. Piridoxilate-associated calcium oxalate urinary calculi: a new metabolic drug-induced nephrolithiasis.
    Daudon M; Reveillaud RJ; Jungers P
    Lancet; 1985 Jun; 1(8441):1338. PubMed ID: 2860529
    [No Abstract]   [Full Text] [Related]  

  • 2. Piridoxilate-associated nephrocalcinosis: a new form of chronic oxalate nephropathy.
    Vigeral P; Kenouch S; Chauveau D; Mougenot B; Méry JP
    Nephrol Dial Transplant; 1987; 2(4):275-8. PubMed ID: 3118272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piridoxilate-induced calcium oxalate calculi: a new drug-induced metabolic nephrolithiasis.
    Daudon M; Reveillaud RJ; Normand M; Petit C; Jungers P
    J Urol; 1987 Aug; 138(2):258-61. PubMed ID: 3599232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrent calcium oxalate calculi in patients treated with piridoxylate].
    Daudon M; Reveilland RJ; Jungers P
    Presse Med; 1985 Apr; 14(15):846-7. PubMed ID: 3158917
    [No Abstract]   [Full Text] [Related]  

  • 5. [Iatrogenic oxalic lithiasis caused by pyridoxilate].
    Wolf C; Maistre-Charransol G; Barthelemy C; Ottavioli JN; Thomas E; Thomas J
    Nephrologie; 1985; 6(5):225-7. PubMed ID: 4094636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of the oxalate precursors on the experimental calcium oxalate urolithiasis].
    Morozumi M; Ogawa Y; Tanaka T; Yamaguchi K; Kitagawa R
    Nihon Hinyokika Gakkai Zasshi; 1987 Jun; 78(6):1025-31. PubMed ID: 3682493
    [No Abstract]   [Full Text] [Related]  

  • 7. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis.
    Urivetzky M; Kessaris D; Smith AD
    J Urol; 1992 May; 147(5):1215-8. PubMed ID: 1569652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piridoxilate-induced oxalate nephropathy can lead to end-stage renal failure.
    Mousson C; Justrabo E; Rifle G; Sgro C; Chalopin JM; Gérard C
    Nephron; 1993; 63(1):104-6. PubMed ID: 8446234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute renal failure caused by acute oxalosis after massive ingestion of pyridoxilate].
    Dequiedt P; Gosselin B; Benoit O; Le Maguer D; Lebleu J; MacNamara E; Pagniez D; Dracon M; Lelièvre G; Tacquet A
    Nephrologie; 1985; 6(5):228-30. PubMed ID: 4094637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium oxalate stones and hyperoxaluria secondary to treatment with pyridoxilate].
    Wolf C; Maistre-Charransol G; Barthélémy C; Thomas E; Thomas J; Arvis G; Steg A
    Ann Urol (Paris); 1985; 19(5):313-7. PubMed ID: 4083839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of hypocitruria in calcium oxalate induced nephrolithiasis].
    Horváth C; Németh J; Büki B; Vargha P
    Orv Hetil; 1990 Nov; 131(45):2475-8. PubMed ID: 2234941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid/calcium oxalate nephrolithiasis. Clinical and biochemical findings in 86 patients.
    Rapado A; Castrillo JM; Diaz-Curiel M; Traba ML; Santos M; Cifuentes-Delatte L
    Adv Exp Med Biol; 1980; 122A():109-13. PubMed ID: 7424622
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium oxalate crystalluria in elderly patients and treatment with naftidrofuryl oxalate.
    Moesch C; Charmes JP; Bouthier F; Leroux-Robert C
    Age Ageing; 1995 Nov; 24(6):464-7. PubMed ID: 8588533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperoxaluria in idiopathic calcium oxalate nephrolithiasis.
    Yendt ER
    Md Med J; 1988 Nov; 37(11):857-60. PubMed ID: 3185157
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: implications for prevention of osteoporosis.
    Levine BS; Rodman JS; Wienerman S; Bockman RS; Lane JM; Chapman DS
    Am J Clin Nutr; 1994 Oct; 60(4):592-6. PubMed ID: 8092096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [13 cases of drug-induced calculi].
    Teillac P; Daudon M; de Dreuzy O; Nguyen HV; Reveillaud RJ; Le Duc A
    Ann Urol (Paris); 1988; 22(4):278-81. PubMed ID: 2903714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis.
    Nakagawa Y; Parks JH; Kézdy FJ; Coe FL
    Trans Assoc Am Physicians; 1985; 98():281-9. PubMed ID: 3842199
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of diclofenac-Na on 24-hour urinary excretion of creatinine, calcium, uric acid and glycosaminoglycans in adult patients with recurrent calcium oxalate nephrolithiasis.
    Hemal AK; Sidhu H; Thind SK; Nath R; Vaidyanathan S
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):44-6. PubMed ID: 2744906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.